Clinical Trials

NCT04462406 | ACTIVE_NOT_RECRUITING | PHASE2
150 participants

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-14
Start Date:
2021-02-09
Completion:
2027-01-31
Conditions
  • Advanced Melanoma
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Melanoma of Unknown Primary
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIID Cutaneous Melanoma AJCC v8
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8
  • Unresectable Acral Lentiginous Melanoma
  • Unresectable Melanoma
  • Unresectable Mucosal Melanoma
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT04394546 | ACTIVE_NOT_RECRUITING | NA
3000 participants

CHAMPION-AF Clinical Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-14
Start Date:
2020-10-15
Completion:
2027-12-31
Conditions
  • Atrial Fibrillation
  • Stroke
  • Bleeding
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT04295252 | RECRUITING
3000 participants

Altshock-2 REGISTRY

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-14
Start Date:
2020-07-01
Completion:
2030-12-31
Conditions
  • Cardiogenic Shock
No Results Yet
NCT04110522 | ACTIVE_NOT_RECRUITING | NA
18000 participants

Psoriatic Arthritis D2P Screening

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-14
Start Date:
2019-07-22
Completion:
2027-12-31
Conditions
  • Psoriatic Arthritis
Interventions
  • OTHER
No Results Yet
NCT04057651 | COMPLETED
800 participants

Hip and Knee Scores

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-14
Start Date:
2018-08-28
Completion:
2020-05-19
Conditions
  • Hip Osteoarthritis
  • Knee Osteoarthritis
No Results Yet
NCT04030559 | TERMINATED | PHASE2
11 participants

Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-14
Start Date:
2020-02-25
Completion:
2024-01-10
Conditions
  • ATM Gene Mutation
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • BRIP1 Gene Mutation
  • CDK12 Gene Mutation
  • CHEK1 Gene Mutation
  • CHEK2 Gene Mutation
  • DNA Damage Response Gene Mutation
  • DNA Repair Gene Mutation
  • FANCA Gene Mutation
  • FANCD2 Gene Mutation
  • FANCL Gene Mutation
  • GEN1 Gene Mutation
  • NBN Gene Mutation
  • Prostate Carcinoma
  • RAD51 Gene Mutation
  • RAD51C Gene Mutation
Interventions
  • DRUG
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page